Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Cumulative Risks of Multiple Criminal Justice Outcomes in New York City.

Hepburn P, Kohler-Hausmann I, Zorro Medina A.

Demography. 2019 Apr 30. doi: 10.1007/s13524-019-00781-7. [Epub ahead of print]

PMID:
31041605
2.

Cultural Mechanisms in Neighborhood Effects Research in the United States.

Harding DJ, Hepburn P.

Sociol Urbana Rurale (Testo Stamp). 2014;103:37-73.

3.

Causality methods in cosmetovigilance: comparison of Colipa and PLM versus global introspection.

Zweers PG, Gilmour NJ, Hepburn PA, Gerritsen RF, van Puijenbroek EP.

Regul Toxicol Pharmacol. 2012 Aug;63(3):409-17. doi: 10.1016/j.yrtph.2012.05.005. Epub 2012 May 17.

PMID:
22609380
4.

Approaches to the safety assessment of engineered nanomaterials (ENM) in food.

Cockburn A, Bradford R, Buck N, Constable A, Edwards G, Haber B, Hepburn P, Howlett J, Kampers F, Klein C, Radomski M, Stamm H, Wijnhoven S, Wildemann T.

Food Chem Toxicol. 2012 Jun;50(6):2224-42. doi: 10.1016/j.fct.2011.12.029. Epub 2011 Dec 29. Review.

PMID:
22245376
5.

The application of post-market monitoring to novel foods.

Hepburn P, Howlett J, Boeing H, Cockburn A, Constable A, Davi A, de Jong N, Moseley B, Oberdörfer R, Robertson C, Wal JM, Samuels F.

Food Chem Toxicol. 2008 Jan;46(1):9-33. Epub 2007 Sep 14. Review.

PMID:
17950974
6.

History of safe use as applied to the safety assessment of novel foods and foods derived from genetically modified organisms.

Constable A, Jonas D, Cockburn A, Davi A, Edwards G, Hepburn P, Herouet-Guicheney C, Knowles M, Moseley B, Oberdörfer R, Samuels F.

Food Chem Toxicol. 2007 Dec;45(12):2513-25. Epub 2007 Jun 21.

PMID:
17692450
7.

Post Launch Monitoring of food products: what can be learned from pharmacovigilance.

van Puijenbroek EP, Hepburn PA, Herd TM, van Grootheest AC.

Regul Toxicol Pharmacol. 2007 Mar;47(2):213-20. Epub 2007 Jan 3.

PMID:
17204356
8.

Safety evaluation of phytosterol-esters. Part 9: Results of a European post-launch monitoring programme.

Lea LJ, Hepburn PA.

Food Chem Toxicol. 2006 Aug;44(8):1213-22. Epub 2006 Mar 20.

PMID:
16542769
9.

Safety evaluation of phytosterol esters. Part 8. Lack of genotoxicity and subchronic toxicity with phytosterol oxides.

Lea LJ, Hepburn PA, Wolfreys AM, Baldrick P.

Food Chem Toxicol. 2004 May;42(5):771-83.

PMID:
15046823
10.

An investigation of the general, reproductive and postnatal developmental toxicity of Betapol, a human milk fat equivalent.

Spurgeon MJ, Palmer AK, Hepburn PA.

Food Chem Toxicol. 2003 Oct;41(10):1355-66.

PMID:
12909269
11.

Post-market surveillance of GM foods: applicability and limitations of schemes used with pharmaceuticals and some non-GM novel foods.

Wal JM, Hepburn PA, Lea LJ, Crevel RW.

Regul Toxicol Pharmacol. 2003 Aug;38(1):98-104. Review.

PMID:
12878059
12.

Studies to investigate the absorption and excretion of shea oleine sterols in rat and man.

Earl LK, Baldrick P, Hepburn PA.

Int J Toxicol. 2002 Sep-Oct;21(5):353-9.

PMID:
12396680
13.
14.

Loss of ACTH expression in cultured human corticotroph macroadenoma cells is consistent with loss of the POMC gene signal sequence.

Rees DA, Hepburn PJ, McNicol AM, Francis K, Jasani B, Lewis MD, Farrell WE, Lewis BM, Scanlon MF, Ham J.

Mol Cell Endocrinol. 2002 Mar 28;189(1-2):51-7.

PMID:
12039064
15.

A 13-week feeding study in the rat with shea oleine and hardened shea oleine.

Earl LK, Baldrick P, Hepburn PA.

Int J Toxicol. 2002 Jan-Feb;21(1):13-22.

PMID:
11936895
17.

Reproduction studies in the rat with shea oleine and hardened shea oleine.

Baldrick P, Robinson JA, Hepburn PA.

Food Chem Toxicol. 2001 Sep;39(9):923-30.

PMID:
11498269
18.

An assessment of the carcinogenic potential of shea oleine in the rat.

Carthew P, Baldrick P, Hepburn PA.

Food Chem Toxicol. 2001 Aug;39(8):807-15.

PMID:
11434988
19.

A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer.

Johnson PW, Muers MF, Peake MD, Poulter KM, Gurney EM, Napp VV, Hepburn PM, Brown JM.

Br J Cancer. 2001 Jan 5;84(1):19-24.

20.

Comments on the review by Nguyen et al. (1999). "The cholesterol-lowering action of plant stanol esters".

Ntanios F, Meijer G, Hepburn P.

J Nutr. 2000 Sep;130(9):2390-2. No abstract available.

PMID:
10958841
21.

Evidence for a telomere-independent "clock" limiting RAS oncogene-driven proliferation of human thyroid epithelial cells.

Jones CJ, Kipling D, Morris M, Hepburn P, Skinner J, Bounacer A, Wyllie FS, Ivan M, Bartek J, Wynford-Thomas D, Bond JA.

Mol Cell Biol. 2000 Aug;20(15):5690-9.

22.

The safety evaluation of phytosterol esters. Part 6. The comparative absorption and tissue distribution of phytosterols in the rat.

Sanders DJ, Minter HJ, Howes D, Hepburn PA.

Food Chem Toxicol. 2000 Jun;38(6):485-91.

PMID:
10828500
24.

Safety evaluation of phytosterol esters. Part 3. Two-generation reproduction study in rats with phytosterol esters--a novel functional food.

Waalkens-Berendsen DH, Wolterbeek AP, Wijnands MV, Richold M, Hepburn PA.

Food Chem Toxicol. 1999 Jul;37(7):683-96. Erratum in: Food Chem Toxicol 2002 Nov;40(11):1729.

PMID:
10496369
25.
26.

Safety evaluation of phytosterol esters. Part 1. Assessment of oestrogenicity using a combination of in vivo and in vitro assays.

Baker VA, Hepburn PA, Kennedy SJ, Jones PA, Lea LJ, Sumpter JP, Ashby J.

Food Chem Toxicol. 1999 Jan;37(1):13-22.

PMID:
10069478
27.

Assessment of the carcinogenic potential of polyglycerol polyricinoleate (PGPR) in rats and mice.

Smith MR, Wilson R, Hepburn PA.

Food Chem Toxicol. 1998 Sep-Oct;36(9-10):747-54.

PMID:
9737421
28.

Immortalized human pituitary cells express glycoprotein alpha-subunit and thyrotropin beta (TSH beta).

Ham J, Webster J, Bond JA, Jasani B, Lewis MD, Hepburn PJ, Davies JS, Lewis BM, Thomas DW, Scanlon MF.

J Clin Endocrinol Metab. 1998 May;83(5):1598-603.

PMID:
9589662
29.

Angiogenic factors expressed by human prostatic cell lines: effect on endothelial cell growth in vitro.

Hepburn PJ, Griffiths K, Harper ME.

Prostate. 1997 Oct 1;33(2):123-32.

PMID:
9316653
30.

Epidermal growth factor protects GH3 cells from adenosine induced growth arrest.

Lewis MD, Hepburn PJ, Scanlon MF.

Mol Cell Endocrinol. 1997 Mar 28;127(2):137-42.

PMID:
9099909
31.

A cautionary note regarding the application of Ki-67 antibodies to paraffin-embedded breast cancers.

Gee JM, Douglas-Jones A, Hepburn P, Sharma AK, McClelland RA, Ellis IO, Nicholson RI.

J Pathol. 1995 Nov;177(3):285-93.

PMID:
8551391
32.

Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNA.

Hepburn PJ, Glynne-Jones E, Goddard L, Gee JM, Harper ME.

Histochem J. 1995 Mar;27(3):196-203.

PMID:
7797424
33.

Enzymatic methylation of cytosine in DNA is prevented by adjacent O6-methylguanine residues.

Hepburn PA, Margison GP, Tisdale MJ.

J Biol Chem. 1991 May 5;266(13):7985-7.

34.

Importance of the O6 position of guanine residues in the binding of DNA methylase to DNA.

Hepburn PA, Tisdale MJ.

Biochim Biophys Acta. 1991 Mar 26;1088(3):341-4.

PMID:
2015298
35.
36.

A dose of preventive medicine.

Hepburn P.

Br J Hosp Med. 1989 Sep;42(3):244, 246. No abstract available.

PMID:
2790371
37.

Inheritance tax.

Hepburn PF.

Br J Hosp Med. 1986 Nov;36(5):382, 384. No abstract available.

PMID:
3790864
38.

Your accounts. The case for unit trusts.

Hepburn PF.

Br J Hosp Med. 1986 Oct;36(4):297-8. No abstract available.

PMID:
3768622
39.

Completing your tax return.

Hepburn PF.

Br J Hosp Med. 1986 Sep;36(3):222-4. No abstract available.

PMID:
3768610
40.

Human bladder cancer in vitro drug sensitivities: range and stability in long-term culture.

Masters JR, Hepburn PJ.

Br J Cancer. 1986 Jul;54(1):131-5. No abstract available.

41.

Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines.

Masters JR, Hepburn PJ, Walker L, Highman WJ, Trejdosiewicz LK, Povey S, Parkar M, Hill BT, Riddle PR, Franks LM.

Cancer Res. 1986 Jul;46(7):3630-6.

42.

Insurance review: 1.

Hepburn PF.

Br J Hosp Med. 1986 Jun;35(6):429-31. No abstract available.

PMID:
3719213
43.

Budget 1986.

Hepburn PF.

Br J Hosp Med. 1986 May;35(5):349, 351. No abstract available.

PMID:
3719202
44.

Managing the practice: 2.

Hepburn PF.

Br J Hosp Med. 1986 Apr;35(4):274, 276. No abstract available.

PMID:
3719193
45.

Managing the practice: 1.

Hepburn PF.

Br J Hosp Med. 1986 Mar;35(3):201-2. No abstract available.

PMID:
3742134
46.

Self assessment.

Hepburn PF.

Br J Hosp Med. 1986 Feb;35(2):129-30. No abstract available.

PMID:
3730666
47.

Influence of clonogenic assay methodology on measurement of drug sensitivities in vitro.

Hepburn PJ, Masters JR.

Cancer Chemother Pharmacol. 1986;16(1):80-2.

PMID:
3940224
48.

Intravesical chemotherapy: in vitro studies on the relationship between dose and cytotoxicity.

Walker MC, Masters JR, Parris CN, Hepburn PJ, English PJ.

Urol Res. 1986;14(3):137-40.

PMID:
3092427
49.

Farms and woodlands.

Hepburn PF.

Br J Hosp Med. 1985 Dec;34(6):376-7. No abstract available.

PMID:
4084709
50.

Investment opportunities.

Hepburn PF.

Br J Hosp Med. 1985 Nov;34(5):311-2. No abstract available.

PMID:
3836726

Supplemental Content

Loading ...
Support Center